About Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia
Clinical Trials at Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia
During the past decade, Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on
average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia
According to Clinical.Site data, the most researched conditions in "Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia" are
"Non-Hodgkin's Lymphoma" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Paroxysmal Nocturnal Hemoglobinuria" (2 trials), "Chronic Lymphocytic Leukemia (CLL)" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia
Most popular intervention types in "Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Obinutuzumab" (4 trials), "Rituximab" (4 trials), "Bendamustine" (3 trials), "Cyclophosphamide" (3 trials) and "Crovalimab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia
The vast majority of trials in "Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia" are
10 trials for "All" genders.
Clinical Trials Status at Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia
Currently, there are NaN active trials in "Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia, 2 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".